Minosiklin etkileşimleri

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (Minosiklin etiketi, Uyarılar ve önlemler)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Minosiklin etiketi, İlaç etkileşimleri)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Minosiklin etiketi, İlaç etkileşimleri)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Minosiklin etiketi, İlaç etkileşimleri)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Minosiklin etiketi, İlaç etkileşimleri)

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (Minosiklin etiketi, Uyarılar ve önlemler)

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (Minosiklin etiketi, Uyarılar ve önlemler)

EMROSI is contraindicated in patients with a history of hypersensitivity to any of the tetracyclines [see Warnings and Precautions (5.1) ]. (Minosiklin etiketi, Kontrendikasyonlar)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Minosiklin etiketi, İlaç etkileşimleri)

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (Minosiklin etiketi, Uyarılar ve önlemler)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Minosiklin etiketi, İlaç etkileşimleri)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Minosiklin etiketi, İlaç etkileşimleri)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Minosiklin etiketi, İlaç etkileşimleri)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Minosiklin etiketi, İlaç etkileşimleri)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Minosiklin etiketi, İlaç etkileşimleri)

EMROSI is contraindicated in patients with a history of hypersensitivity to any of the tetracyclines [see Warnings and Precautions (5.1) ]. (Minosiklin etiketi, Kontrendikasyonlar)

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (Minosiklin etiketi, Uyarılar ve önlemler)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Minosiklin etiketi, İlaç etkileşimleri)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Minosiklin etiketi, İlaç etkileşimleri)

• Concomitant administration of tetracycline reduces atovaquone concentrations; use caution when coadministering. (Atovakuon etiketi, İlaç etkileşimleri)

• Tetracycline may reduce atovaquone concentrations; parasitemia should be closely monitored. (Atovakuon ve proguanil etiketi, İlaç etkileşimleri)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Minosiklin etiketi, İlaç etkileşimleri)

Çinko, kinolon ve tetrasiklin antibiyotiklerin emilimini azaltır; antibiyotiği çinkodan en az iki saat önce veya dört ila altı saat sonra alın. (NIH Office of Dietary Supplements, Zinc)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Minosiklin etiketi, İlaç etkileşimleri)

Demir bu ilaçları bağırsakta bağlar ve emilimlerini azaltır; dozları ayrı zamanlarda alın. (NIH Office of Dietary Supplements, Iron)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Minosiklin etiketi, İlaç etkileşimleri)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Minosiklin etiketi, İlaç etkileşimleri)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Minosiklin etiketi, İlaç etkileşimleri)

…antagonists, fibrates, propoxyphene, pentoxifylline, somatostatin analogs, anabolic steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs that are highly protein-bound, such as fluoxetine, nonsteroidal anti-inflammatory drugs, salicylates, sulfonamides,… (Glimepirid etiketi, İlaç etkileşimleri)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Minosiklin etiketi, İlaç etkileşimleri)

Kalsiyum bu ilaçları bağırsakta bağlar ve emilen miktarı keskin biçimde azaltabilir; dozları ayrı zamanlarda alın. (NIH Office of Dietary Supplements, Calcium)

Calcium acetate capsules may decrease the bioavailability of tetracyclines or fluoroquinolones via this mechanism. (Kalsiyum asetat etiketi, İlaç etkileşimleri)

Tetracycline and other drugs that interact with magnesium Simultaneous administration of tetracycline with quinapril hydrochloride reduced the absorption of tetracycline by approximately 28% to 37%, possibly due to the high magnesium content in quinapril tablets. (Kinapril etiketi, İlaç etkileşimleri)

Although tetracycline may be concomitantly administered with quinine sulfate, patients should be monitored closely for adverse reactions associated with quinine sulfate. (Kinin etiketi, İlaç etkileşimleri)

The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride. (Kolestipol etiketi, İlaç etkileşimleri)

Drug Interactions Cholestyramine for Oral Suspension USP may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic), or propranolol (basic), as well as tetracycline, penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis. (Kolestiramin etiketi, İlaç etkileşimleri)

Examples of relevant classes of compounds where antacids have been demonstrated to reduce bioavailability include antibiotics (such as quinolones, ampicillin, and tetracyclines), thyroid hormones, ACE inhibitors, statin lipid regulators, and anti-malarials. (Lantan etiketi, İlaç etkileşimleri)

Caution should be exercised when JUXTAPID is used with other medications known to have potential for hepatotoxicity, such as isotretinoin, amiodarone, acetaminophen (>4 g/day for ≥3 days/week), methotrexate, tetracyclines, and tamoxifen. (Lomitapid etiketi, Uyarılar ve önlemler)

Magnezyum içeren takviyeler ve antasitler bu ilaçların emilimini azaltır; dozların arasına en az iki saat koyun. (NIH Office of Dietary Supplements, Magnesium)

…antagonists, fibrates, propoxyphene, pentoxifylline, somatostatin analogs, anabolic steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs that are highly protein-bound, such as fluoxetine, nonsteroidal anti-inflammatory drugs, salicylates, sulfonamides,… (Pioglitazon ve glimepirid etiketi, İlaç etkileşimleri)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Minosiklin etiketi, İlaç etkileşimleri)

Antibiotics Drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as Rocuronium Bromide Injection include certain antibiotics (e.g., aminoglycosides; vancomycin; tetracyclines; bacitracin; polymyxins; colistin; and sodium colistimethate). (Rokuronyum etiketi, İlaç etkileşimleri)

Drug Interactions Some studies have shown that simultaneous sucralfate administration in healthy volunteers reduced the extent of absorption (bioavailability) of single doses of the following: cimetidine, digoxin, fluoroquinolone antibiotics, ketoconazole, l-thyroxine, phenytoin, quinidine, ranitidine, tetracycline, and theophylline. (Sukralfat etiketi, İlaç etkileşimleri)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (Minosiklin etiketi, İlaç etkileşimleri)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (Minosiklin etiketi, İlaç etkileşimleri)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (Minosiklin etiketi, İlaç etkileşimleri)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (Minosiklin etiketi, İlaç etkileşimleri)

WARNINGS DEMECLOCYCLINE HYDROCHLORIDE, LIKE OTHER TETRACYCLINE-CLASS ANTIBIOTICS, CAN CAUSE FETAL HARM WHEN ADMINISTERED TO A PREGNANT WOMAN. (Demeklosiklin etiketi, Uyarılar)

A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (Etinodiol diasetat ve etinilestradiol etiketi, İlaç etkileşimleri)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (Minosiklin etiketi, İlaç etkileşimleri)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (Minosiklin etiketi, Uyarılar ve önlemler)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (Minosiklin etiketi, Uyarılar ve önlemler)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (Minosiklin etiketi, Uyarılar ve önlemler)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (Minosiklin etiketi, Uyarılar ve önlemler)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (Minosiklin etiketi, İlaç etkileşimleri)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (Minosiklin etiketi, Uyarılar ve önlemler)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (Minosiklin etiketi, İlaç etkileşimleri)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (Minosiklin etiketi, Uyarılar ve önlemler)

The following antibiotics have been associated with various degrees of paralysis: aminoglycosides (such as neomycin, streptomycin, kanamycin, gentamicin, and dihydrostreptomycin); tetracyclines; bacitracin; polymyxin B; colistin; and sodium colistimethate. (Vekuronyum etiketi, Önlemler)

…omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinical use are immunoassays which are specific… (Aminofilin etiketi, İlaç etkileşimleri)

…additional doses of Cisatracurium Besylate Injection, and to determine whether adjustments need to be made to the dose with subsequent administration. † Examples: aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, sodium colistimethate Drug or Drug Class Clinical Implications * Succinylcholine The use of succinylcholine… (Sisatrakuryum etiketi, İlaç etkileşimleri)

…ranitidine famotidine rifabutin felodipine roxithromycin finasteride Sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin * Refer to PRECAUTIONS , Drug Interactions for information regarding table. (Teofilin etiketi, İlaç etkileşimleri)